This company has a mixed profile, with a positive price trend and a healthy balance sheet, although its growth has been slow.
Quant Score on a 1–100 scale, computed Oct 25, 6:22 PM EDT from the data shown on this page. It describes the company’s current profile — it is not a price prediction or a recommendation. How it’s calculated
Tap any area to see the numbers it is based on.
The case for, the case against, and what to watch.
Is the business growing, profitable and able to carry its debt?
Is the stock reasonably priced?
The stock looks reasonably priced relative to its earnings and cash flow.
See how it stacks up on quality, growth, valuation, risk and momentum.
Is this a profitable, well-run business?
Weak. Weakest: net margin (ttm) at 2.2%.
| Input | Value | Points /10 |
|---|---|---|
| Return on equity (TTM) | 5.3% | 0.1 |
| Return on invested capital (TTM) | 15.5% | 5.5 |
| Operating margin (TTM) | 14.0% | 3.0 |
| Net margin (TTM) | 2.2% | 0.1 |
| Free cash flow / operating cash flow | 47% | 2.9 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is this a financially healthy business?
Strong. Strongest signal: piotroski f-score at 8/9. Weakest: altman z-score at 2.66.
| Input | Value | Points /10 |
|---|---|---|
| Piotroski F-Score | 8/9 | 10.0 |
| Altman Z-Score | 2.66 | 2.1 |
| Debt / Equity | 0.48 | 8.0 |
| Current ratio | 1.4x | 3.5 |
| Interest coverage | 131.5x | 10.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is the stock expensive?
Reasonably priced. Strongest signal: peg at 0.16. Weakest: dcf upside at -31.8%.
| Input | Value | Points /10 |
|---|---|---|
| P/E (TTM) | 33.5x | 5.5 |
| PEG | 0.16 | 10.0 |
| Price / FCF | 22.1x | 7.9 |
| EV / EBITDA | 11.5x | 8.9 |
| DCF upside | -31.8% | 1.2 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is the company growing?
Slow or shrinking. Weakest: net income growth (fy) at -828.2%.
| Input | Value | Points /10 |
|---|---|---|
| Revenue growth (FY) | 5.0% | 2.2 |
| Net income growth (FY) | -828.2% | 0.0 |
| Revenue CAGR (3Y) | 5.1% | 1.7 |
| Forward revenue growth | -5.0% | 0.0 |
| Gross margin | 45.1% | 5.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is the stock price showing strength?
Positive. Strongest signal: rsi (14) at 46.9. Weakest: signal consensus at Sell.
| Input | Value | Points /10 |
|---|---|---|
| Trend alignment (50/200 SMA) | 2/3 | 6.7 |
| RSI (14) | 46.9 | 10.0 |
| MACD histogram | 0.02 | 10.0 |
| Signal consensus | Sell | 4.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
What do professional analysts think?
Not enough data to score this area.
| Input | Value | Points /10 |
|---|---|---|
| Analyst buy share | — | n/a |
| Target upside | — | n/a |
| 90-day rating revisions | 0↑ / 0↓ | n/a |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
What could go wrong?
Elevated risk. Strongest signal: beta (vs. market) at -0.03. Weakest: price volatility (1y, annualised) at 57%.
| Input | Value | Points /10 |
|---|---|---|
| Beta (vs. market) | -0.03 | 10.0 |
| Price volatility (1Y, annualised) | 57% | 0.7 |
| Largest 1Y drawdown | -25% | 5.9 |
| Net debt / EBITDA | 1.4x | 6.4 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
A formula-based estimate from projected cash flows. Small changes in assumptions move it a lot — treat it as one input, not a price the stock will reach.
No analyst targets available.
Source: Financial Modeling Prep · P/E trailing twelve months; history from annual filings · USD · data as of Oct 25, 2026
Revenue is what customers paid the company. Over 4 years it has grown about 5% a year on average.
Net income is the profit left after all costs and taxes. It has been negative over the period shown.
Cash the business generates after investing in itself — what can fund dividends, buybacks or growth. It has turned positive over the period shown.
Share of sales left after the direct cost of products.
Share of sales left after running the business.
Share of sales kept as profit.
Debt is moderate compared with shareholders' equity.
The company earns a high return on the money invested in it.
Profits cover interest payments many times over.
Source: Financial Modeling Prep · annual filings FY2021–FY2025; margins and ratios trailing twelve months · USD · data as of Oct 25, 2026
